Morgan Stanley Resumes Abbvie (ABBV) at Equalweight
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $250.33 +0.35%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 4 | New: 5
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 4 | New: 5
Join SI Premium – FREE
Morgan Stanley resumed coverage on Abbvie (NYSE: ABBV) with an Equalweight rating.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $67.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- Goldman Sachs Starts Scribe Therapeutics Inc (SCTX) at Early-Stage Biotech
- Canaccord Starts Sunshine Silver Mining & Refining (SSMR) at Spec. Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
